A Look At Pediatrix Medical Group (MD) Valuation After Earnings Show Lower Sales But Stronger Profitability

Simply Wall St.

02/19

AdvertisementWhy Pediatrix Medical Group is on investors’ radar today Pediatrix Medical Group (MD) released Q4 and full year 2025 results showing lower sales alongside higher net income and earnings ...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2612283442"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612283442\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612283442?lang=zh_CN&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-02-19 22:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612283442","market":"us","top_or_hot":-1,"title":"A Look At Pediatrix Medical Group (MD) Valuation After Earnings Show Lower Sales But Stronger Profitability","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy Pediatrix Medical Group is on investors’ radar today Pediatrix Medical Group (MD) released Q4 and full year 2025 results showing lower sales alongside higher net income and earnings ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-md/pediatrix-medical-group/news/a-look-at-pediatrix-medical-group-md-valuation-after-earning\">网页链接</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Pediatrix Medical Group (MD) Valuation After Earnings Show Lower Sales But Stronger Profitability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Pediatrix Medical Group (MD) Valuation After Earnings Show Lower Sales But Stronger Profitability\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-19 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-md/pediatrix-medical-group/news/a-look-at-pediatrix-medical-group-md-valuation-after-earning><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy Pediatrix Medical Group is on investors’ radar today Pediatrix Medical Group (MD) released Q4 and full year 2025 results showing lower sales alongside higher net income and earnings ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-md/pediatrix-medical-group/news/a-look-at-pediatrix-medical-group-md-valuation-after-earning\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MD","symbol_name":"Pediatrix Medical","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-md/pediatrix-medical-group/news/a-look-at-pediatrix-medical-group-md-valuation-after-earning","article_id":"2612283442","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-md/pediatrix-medical-group/news/a-look-at-pediatrix-medical-group-md-valuation-after-earning","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2612283442","pubTimestamp":1771511238,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why Pediatrix Medical Group is on investors’ radar today\nPediatrix Medical Group (MD) released Q4 and full year 2025 results showing lower sales alongside higher net income and earnings per share, catching investor attention as the market absorbs this mixed top and bottom line picture.\nSee our latest analysis for Pediatrix Medical Group.\nThe latest move in Pediatrix Medical Group’s share price to US$21.97 comes after a year where shorter term share price returns were mixed, while the 1 year...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"MD":"Pediatrix Medical"},"translate_title":"Pediatrix Medical Group(MD)盈利显示销售额下降但盈利能力增强后的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MD":1.5},"content_text":"AdvertisementWhy Pediatrix Medical Group is on investors’ radar today Pediatrix Medical Group (MD) released Q4 and full year 2025 results showing lower sales alongside higher net income and earnings per share, catching investor attention as the market absorbs this mixed top and bottom line picture. See our latest analysis for Pediatrix Medical Group. The latest move in Pediatrix Medical Group’s share price to US$21.97 comes after a year where shorter term share price returns were mixed, while the 1 year total shareholder return of 55.7% points to stronger momentum building over a longer stretch. If Pediatrix’s earnings swing has you thinking about where else returns might be shifting in healthcare, it could be a good time to scan 25 healthcare AI stocks as a starting list of ideas. With Pediatrix Medical Group trading close to analyst price targets yet showing an intrinsic value estimate at a sizable discount, the key question is whether the recent earnings shift presents a genuine opportunity or whether the market is already pricing in future growth. Most Popular Narrative: 3.1% Undervalued With Pediatrix Medical Group closing at $21.97 against a widely followed fair value estimate of about $22.67, the current setup hinges on steady growth and margins rather than big swings in expectations.  Ongoing operational improvements, such as enhancements in revenue cycle management and tightly controlled salary expenses, are improving working capital efficiency and holding down expense growth, supporting higher net earnings and cash flow conversion.  Read the complete narrative. Curious how modest revenue growth, firmer margins and a slightly lower future earnings multiple still support this valuation? The full narrative spells out the exact earnings path behind that fair value and how the discount rate ties it all together. Result: Fair Value of $22.67 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, portfolio restructuring driven revenue declines, along with rising salary and benefits costs, could challenge margin gains and put the current fair value narrative to the test. Find out about the key risks to this Pediatrix Medical Group narrative. Next Steps If this mix of cautious optimism and concern resonates with you, it is worth looking through the numbers yourself and forming a clear view while the market is still rebalancing expectations. You can start with 3 key rewards and 1 important warning sign. Looking for more investment ideas? If this update has sharpened your thinking, do not stop at one company. Use the Simply Wall Street Screener to spot where your next opportunity might be hiding.  Target consistent cash returns by scanning companies we see as potential 13 dividend fortresses that might suit income focused portfolios. Hunt for value by reviewing our 53 high quality undervalued stocks and see which names currently screen as priced below their fundamentals. Prioritise capital protection by checking out 80 resilient stocks with low risk scores, a starting list for investors who want resilience front and center.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}